Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).
Ozawa M, Watanabe J, Ishibe A, Goto K, Fujii Y, Nakagawa K, Suwa Y, Suwa H, Masui H, Sugita M, Mochizuki Y, Yamagishi S, Hasegawa S, Homma Y, Momiyama M, Kumamoto T, Matsuyama R, Takeda K, Taguri M, Endo I.
Ozawa M, et al. Among authors: masui h.
Cancer Chemother Pharmacol. 2024 Jun;93(6):565-573. doi: 10.1007/s00280-024-04648-6. Epub 2024 Feb 19.
Cancer Chemother Pharmacol. 2024.
PMID: 38374403
Clinical Trial.